Duchenne Muscular Dystrophy Treatment Market Share

Statistics for the 2023 & 2024 Duchenne Muscular Dystrophy Treatment market share, created by Mordor Intelligence™ Industry Reports. Duchenne Muscular Dystrophy Treatment share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Genetic Disorder Drugs Research Duchenne Muscular Dystrophy Treatment Market Market Share

Market Share of Duchenne Muscular Dystrophy Treatment Industry

The duchenne muscular dystrophy treatment market is moderately fragmented and consists of several major players. Some of the companies which are currently dominating the market are BioMarin, Fibrogen Inc., Nobelpharma Co. Ltd, NS Pharma Inc., Pfizer Inc., PTC Therapeutics, Santhera Pharmaceuticals, Sarepta Therapeutics, Hoffmann-La Roche AG, and ReveraGen BioPharma among others.

Duchenne Muscular Dystrophy Treatment Market Leaders

  1. Pfizer Inc.

  2. Sarepta Therapeutics

  3. PTC Therapeutics

  4. FibroGen Inc.

  5. F. Hoffmann-La Roche AG

*Disclaimer: Major Players sorted in no particular order

Duchenne Muscular Dystrophy Treatment Market Concentration

Duchenne Muscular Dystrophy Treatment Market Report Snapshots

Duchenne Muscular Dystrophy Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)